OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry
Celeste M. Boesjes, Lian F. van der Gang, Nicolaas P. A. Zuithoff, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00872-adv00872
Open Access | Times Cited: 13
Celeste M. Boesjes, Lian F. van der Gang, Nicolaas P. A. Zuithoff, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00872-adv00872
Open Access | Times Cited: 13
Showing 13 citing articles:
Upadacitinib: Mechanism of action, clinical, and translational science
Mohamed‐Eslam F. Mohamed, Sumit Bhatnagar, Julie Parmentier, et al.
Clinical and Translational Science (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Mohamed‐Eslam F. Mohamed, Sumit Bhatnagar, Julie Parmentier, et al.
Clinical and Translational Science (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv19454-adv19454
Open Access | Times Cited: 13
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv19454-adv19454
Open Access | Times Cited: 13
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 593-604
Open Access | Times Cited: 8
Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 593-604
Open Access | Times Cited: 8
Long-term outcomes of upadacitinib in patients with prior dupilumab exposure: a case series
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Treatment of eosinophilic annular erythema with upadacitinib
Wanyan Xiang, Siqi Zhang, Qiuju Li, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Wanyan Xiang, Siqi Zhang, Qiuju Li, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Atopic Dermatitis
Kang He, Jie Zang, Tingting Ren, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5783-5800
Open Access | Times Cited: 2
Kang He, Jie Zang, Tingting Ren, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5783-5800
Open Access | Times Cited: 2
Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects
Miguel Antonio Lasheras‐Pérez, Rodolfo David Palacios‐Diaz, Mónica Pozuelo‐Ruiz, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 105-107
Closed Access | Times Cited: 4
Miguel Antonio Lasheras‐Pérez, Rodolfo David Palacios‐Diaz, Mónica Pozuelo‐Ruiz, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 105-107
Closed Access | Times Cited: 4
Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report
Mysa Saad, Marina Guirguis, Camille Hamm, et al.
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 1
Mysa Saad, Marina Guirguis, Camille Hamm, et al.
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 1
Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients
Maddalena Napolitano, Silvia Ferrucci, Luciano Foggia, et al.
Clinical Drug Investigation (2023) Vol. 44, Iss. 1, pp. 71-77
Closed Access | Times Cited: 3
Maddalena Napolitano, Silvia Ferrucci, Luciano Foggia, et al.
Clinical Drug Investigation (2023) Vol. 44, Iss. 1, pp. 71-77
Closed Access | Times Cited: 3
Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice
Sandra Martínez‐Fernández, Hae Jin Suh‐Oh, Ana Batalla, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 2
Sandra Martínez‐Fernández, Hae Jin Suh‐Oh, Ana Batalla, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 2
Skin infections in atopic dermatitis: clinic, treatment. A review
D. Sh. Macharadze
Consilium Medicum (2024) Vol. 26, Iss. 8, pp. 498-504
Open Access
D. Sh. Macharadze
Consilium Medicum (2024) Vol. 26, Iss. 8, pp. 498-504
Open Access
Exploring daily practice performance of dupilumab in atopic dermatitis
Lotte S. Spekhorst
(2023)
Open Access
Lotte S. Spekhorst
(2023)
Open Access
Quoi de neuf en thérapeutique dermatologique ?
M. Samimi
Annales de Dermatologie et de Vénéréologie - FMC (2023) Vol. 3, Iss. 8, pp. 8S50-8S65
Closed Access
M. Samimi
Annales de Dermatologie et de Vénéréologie - FMC (2023) Vol. 3, Iss. 8, pp. 8S50-8S65
Closed Access
